drugset / Trial / NCT01766167

Clinical Pharmacology Study of MP-424

NCT01766167

Phase 1 Completed 26 enrolled Tanabe Pharma Corporation
NaSingle-groupOpen-labelBasic science

Summary

To conduct the following evaluations in Korean healthy male adult volunteers receiving a single and multiple doses of MP-424 tablets: * Pharmacokinetics of MP-424 after a single and multiple doses. * Safety and tolerability of single and multiple doses of MP-424.

Timeline

Start
2013-02
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Telaprevir Small molecule